NCT05798676 Maternal Characteristics Associated With Child Growth and Adiposity
| NCT ID | NCT05798676 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 130 participants |
| Start Date | 2019-05-02 |
| Primary Completion | 2028-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 130 participants in total. It began in 2019-05-02 with a primary completion date of 2028-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to investigate the concentrations of leptin, insulin, liver expressed antimicrobial peptide 2 (LEAP2), and cortisol in plasma and breast milk and their relationship with eating behavior, growth, adiposity and with the levels of these hormones in infants, comparing mothers with normal weight and with pre-pregnancy overweight/obesity. The main question\[s\] it aims to answer are: * Are maternal hormones associated with child growth and adiposity * Are maternal hormone receptors associated with child growth and adiposity * Are infant hormones and their receptors associated with child growth and adiposity * Are maternal and infant hormones and their receptors associated with child eating behavior Participants will provide milk and blood samples. Researchers will compare mothers with normal weight and with pre-pregnancy overweight/obesity to see if there are differences in child growth and adiposity .
Eligibility Criteria
Inclusion Criteria: * Lactating women with pre-pregnancy normal weight and overweight or obesity as described by the World Health Organization. Exclusion Criteria: * Diabetes (Type I or II or gestational) * Multiple pregnancy * Hypertensive disorders during pregnancy * Delivery of pre-term infant (\<37 weeks).
Contact & Investigator
Maria F Andreoli, BsC
PRINCIPAL INVESTIGATOR
Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri
Frequently Asked Questions
Who can join the NCT05798676 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 40 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05798676 currently recruiting?
Yes, NCT05798676 is actively recruiting participants. Contact the research team at mfandreoli@gmail.com for enrollment information.
Where is the NCT05798676 trial being conducted?
This trial is being conducted at La Plata, Argentina.
Who is sponsoring the NCT05798676 clinical trial?
NCT05798676 is sponsored by Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri. The principal investigator is Maria F Andreoli, BsC at Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri. The trial plans to enroll 130 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.